ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

0A2V Sanofi Sa

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type Share ISIN Share Description
Sanofi Sa LSE:0A2V London Ordinary Share SANOFI ADR REP 1 1/2 ORD (CDI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 328 -
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Health & Allied Services,nec 43.07B 5.4B 4.2694 21.38 0

Societe Generale SA Stabilisation Notice - SANOFI (9505I)

06/04/2020 3:46pm

UK Regulatory


Sanofi (LSE:0A2V)
Historical Stock Chart


From Dec 2019 to Dec 2024

Click Here for more Sanofi Charts.

TIDM0A2V

RNS Number : 9505I

Societe Generale SA

06 April 2020

Date: 06/04/2020

Not for the distribution, directly or indirectly in to the United States or any jurisdiction in which such distribution would be unlawful.

SANOFI - Stabilisation Notice

Societe Generale (Contact: RONAN MURPHY; telephone: +44-20-7676-7463) hereby gives notice that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).ty

 
              The Securities: 
============================================  ============================================ 
              Issuer:                                       SANOFI 
============================================  ============================================ 
              Guarantor (if any):                           n/a 
============================================  ============================================ 
              Aggregate Nominal Amount:                     EUR 250m, EUR 250m 
============================================  ============================================ 
              Description:                                  Maturity: 1(st) April 2025, 
                                                             1(st) April 2030 
============================================  ============================================ 
              Offer price:                                  102.427, 106.539 
============================================  ============================================ 
              Stabilisation: 
============================================  ============================================ 
              Stabilising managers:                         SG CIB 
============================================  ============================================ 
              Stabilisation Period expected                 06/04/2020 
               to start on: 
============================================  ============================================ 
              Stabilisation period expected                 08/05/2020 
               to end no later than: 
============================================  ============================================ 
              Existence, maximum size                       The Stabilising Manager(s) 
               and conditions of use of                      may over-allot the securities 
               over-allotment facility:                      to the extent permitted 
                                                             in accordance with SG's 
                                                             Policy. 
============================================  ============================================ 
 

In connection with the offer of the above securities, the Stabilising Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any Stabilising action and any Stabilising action, if begun, may be ended at any time. Any Stabilising action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

STAUPUCCCUPUGCQ

(END) Dow Jones Newswires

April 06, 2020 10:46 ET (14:46 GMT)

1 Year Sanofi Chart

1 Year Sanofi Chart

1 Month Sanofi Chart

1 Month Sanofi Chart

Your Recent History

Delayed Upgrade Clock